地缘政治对制药创新的贡献
Michael S Kinch1, Aayan Alawi1, Tyler Schwartz2
1Department of Pharmaceutical Sciences, Stony Brook University, Stony Brook, NY, USA.
Drug discovery today
|December 19, 2025
概括
在过去的25年里,新的实验性药物发现在全球范围内激增. 中国中国中国中国.
科学领域:
- 制药科学 制药科学
- 药物发现和开发 药物发现和开发
- 全球卫生倡议全球卫生倡议
背景情况:
- 美国私营部门历来一直是全球新药引入的领导者.
- 制药创新的景观是充满活力和不断发展的.
- 了解新实验药物的起源对于未来的研发战略至关重要.
研究的目的:
- 分析21世纪新实验药物的地理来源.
- 为了确定药物发现领导层的转变.
- 评估国家战略对制药创新的影响.
主要方法:
- 药物发现组织起源的分析.
- 随着时间的推移,追踪新实验药物的数量和来源.
- 对不同国家和部门的贡献进行比较评估.
主要成果:
- 在过去25年中,新实验药物的总数显著增加.
- 中国已经成为一个主要参与者,现在在新药发现方面与美国的贡献相匹配.
- 中国的增长反映了公共和私营部门的协调努力.
结论:
- 中国的起意味着全球制药研发领导层的重大转变.
- 未来的制药企业决策和领导力将受到这些变化的影响.
- 药物发现的国际合作和竞争动态正在发生变化.
相关概念视频
Biopharmaceutical Factors Influencing Drug Product Design: Overview
218
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
218
Drug Control Governance: Regulatory Bodies and Their Impact
462
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
462
Biopharmaceutics and Pharmacokinetics: Overview
3.2K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
3.2K
Drug Nomenclature
2.9K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
2.9K
Drug Administration and Therapy Phases: Overview
1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
Drug Products: Biologics, Biosimilars and Interchangeables
217
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
217


